Neurochemistry of consciousness: Cholinergic pathologies in the human brain

Progress in Brain Research

Volumn 145, Issue , 2004, Pages 287-299

  Perry, Elaine K ^a   Perry, Robert H ^a  

^a NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ACETYLCHOLINE; ACETYLCHOLINESTERASE; ANTICONVULSIVE AGENT; BENZODIAZEPINE; CHOLINE ACETYLTRANSFERASE; CHOLINESTERASE INHIBITOR; DONEPEZIL; DOPAMINE; GLUTAMIC ACID; MONOAMINE; MUSCARINIC RECEPTOR; NERVE GROWTH FACTOR; NEUROLEPTIC AGENT; NEUROTROPHIN; NICOTINE; NICOTINIC AGENT; NICOTINIC RECEPTOR; NORADRENALIN; PHYSOSTIGMINE; RIVASTIGMINE; SCOPOLAMINE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR;

ALZHEIMER DISEASE; ANALGESIC ACTIVITY; ANXIETY; ATTENTION DEFICIT DISORDER; AUTISM; AWARENESS; BODY POSTURE; BRAIN; BRAIN REGION; CHOLINERGIC NERVE CELL; CHOLINERGIC SYSTEM; CHOLINERGIC TRANSMISSION; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE DEFECT; CONFERENCE PAPER; CONFUSION; CONSCIOUSNESS; CONSCIOUSNESS DISORDER; CORRELATION ANALYSIS; DELUSION; DEMENTIA; DIFFUSE LEWY BODY DISEASE; DREAMING; EPILEPSY; FALLING; GABAERGIC SYSTEM; GILLES DE LA TOURETTE SYNDROME; HALLUCINATION; HUMAN; IMMOBILIZATION; LEWY BODY; MEMORY; MENTAL TASK; NERVE CELL PLASTICITY; NERVE PROJECTION; NERVOUS SYSTEM DEVELOPMENT; NEUROCHEMISTRY; NEUROPATHOLOGY; NONHUMAN; NONREM SLEEP; OPEN STUDY; PAIN; PARASYMPATHETIC INNERVATION; PARKINSON DISEASE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN DEPLETION; REM SLEEP; RETT SYNDROME; RIGIDITY; SCHIZOPHRENIA; SEDATION; SIDE EFFECT; SLOW WAVE SLEEP; TASK PERFORMANCE; THALAMUS NUCLEUS; TREMOR; UNCONSCIOUSNESS;

EID: 0344117998     PISSN: 00796123     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0079-6123(03)45020-6     Document Type: Conference Paper

References (68)

1. Audersirk, T. and Cabell, L. (1999) Nanomolar concentrations of nicotine and cotinine alter the development of cultured hippocampal neurons via non-acetylcholine receptor-mediated mechanisms. Neurotoxicol., 20: 639-646.
2. Baars, B.J. (1998) Metaphors of consciousness and attention in the brain. Trends Neurosci., 21: 58-62.
3. Ballard, C.G., Court, J.A., Piggott, M., Johnson, M., O'Brien, J., Mckeith, I., Holmes, C., Lantos, P., Jaros, E. and Perry, R. and Perry, E. (2002) Disturbances of consciousness in dementia with Lewy bodies associated with alteration in nicotinic receptor binding in the temporal cortex. J Consc. Cognition., in press.
4. Ballard, C., O'Brien, J., Gray, A., Cormack, F., Ayre, G., Rowan, E., Thompson, P., Bucks, R., McKeith, I., Walker, M. and Tovee, M. (2001) Attention and fluctuating attention in patients with dementia with Lewy bodies and Alzheimer's disease. Arch. Neurol., 58: 977-982.
5. Ballard, C., Piggott, M., Johnson, M., Cairns, N.J., Perry, R., McKeith, I., Jaros, E., O'Brien, J., Holmes, C. and Perry, E. (2000) Delusions associated with elevated muscarinic binding in dementia with Lewy bodies. Ann. Neurol., 48: 868-876.
6. Bannon, A.W., Decker, M.W., Holladay, M.W., Curzon, P., Donnelly-Roberts, D., Puttfarcken, P.S., Bitner, R.S., Diaz, A., Dickenson, A.H., Porsolt, R.D., Williams, M. and Arneric, S.P. (1998) Broad-spectrum, non-opioid analgesic activity by selective modulation of neuronal nicotinic acetylcholine receptors. Science, 279: 77-81.
7. Bauman, M.L. and Kemper, T.L. (1994) Neuro-anatomic observations of the brain in Autism. In: M.L. Bauman and T.L. Kemper (Eds.), The Neurobiology of Autism. Johns Hopkins University Press, Baltimore, pp. 119-145.
8. Belluardo, N., Mudo, G., Blum, M., Amato, G. and Fuxe, K. (2000) Neurotrophic effects of central nicotinic receptor activation. J. Neural. Trans. Suppl. 227-245.
9. Blatt, G.J., Fitzgerald, C.M., Guptill, J.T., Booker, A.B., Kemper, T.L. and Bauman, M.L. (2001) Density and distribution of hippocampal neurotransmitter receptors in autism: an autoradiographic study. J. Autism Dev. Disord., 537-543.
10. Bogen, J.E. (1995) On the neurophysiology of consciousness: I. An overview. Cognition, 4: 52-62.
11. Burn, D., Perry, E.K., O'Brien, Y.T., Collerton, D., Yaros, E., Perry, R., Piggott, M.A., Morris, C.M., Mclaren, A.
12. Buzsaki, G., Bickford, R.G., Armstrong, D.M., Ponomareff. G., Chen, K.S., Ruiz, R., Thai, L.J. and Gage, F.H. (1988) Electric activity in the neocortex of freely moving young and aged rats. J. Neurosci., 26: 735-744.
13. Callaway, E. and Band, R.I. (1958) J. Neurol. Psychiat., 79: 91-102.
14. Court, J.A., Lloyd, S., Johnson, M., Griffiths, M., Birdsall, N.J.M., Piggott, M.A., Oakley, A.E., Ince, P.G., Perry, E.K. and Perry, R.H. (1997) Nicotinic and muscarinic cholinergic receptor binding in the human hippocampal formation during development and aging. Dev. Brain Res., 101: 93-105.
15. Court, J.A., Perry, E.K., Johnson, M., Piggott, M.A., Kerwin, J.M., Perry, R.H. and Ince, P.G. (1993) Regional patterns of cholinergic and glutamate activity in the developing and aging human brain. Dev. Brain Res., 74: 73-82.
16. Court, J.A., Martin-Ruiz, C., Graham, A. and Perry, E. (2001) Nicotinic receptors in human brain: topography and pathology. J. Chem. Neuroanat., 20: 281-298.
17. Court, J.A., Ballard, C.G., Piggott, M.A., Johnson, M., O'Brien, J.T., Holmes, C., Cairns, N., Lantos, P., Perry, R.H., Jaros, E. and Perry, E.K. (2001) Visual hallucinations are associated with lower a-bungarotoxin binding in dementia with Lewy bodies., Pharmacol. Biochem. Behav., 70: 571-579.
18. da Penha Berzaghi, M., Cooper, J., Castren, E., Zafra, F., Sofroniew, M., Thoenen, H. and Lindholm, D. (1993) Cholinergic regulation of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) but not neurotrophin-3 (NT-3) mRNA levels in the developing rat hippocampus. J. Neurosci., 13: 3818-3826.
19. Delacour, J. (1995) An introduction to the biology of consciousness. Neuropsychologica, 33: 1061-1074.
20. Fisahn, A., Pike, F.G., Buhl, E.H. and Paulsen, O. (1998) Cholinergic induction of network oscillations at 40 Hz in the hippocampus in vitro. Nature, 394: 186-189.
21. Flood, P. and Role, L.W. (1998) Neuronal nicotinic acetylcholine receptor modulation by general anaesthetics. Toxicol. Lett., 100-101: 149-153.
22. Gomez-Tortosa, E., Newell, K., Irizarry, M.C., Albert, M., Growdon, J.H. and Hyman, B.T. (1999) Clinical and quantitative pathologic correlates of dementia with Lewy bodies. Neurology, 53: 1284-1291.
23. Grace, J., Daniel, S., Stevens, T., Shankar, K.K., Walker, Z., Byrne, E.J., Butler, S., Wilkinson, D., Woolford, J., Waite, J. and McKeith, I.G. (2001) Long-term use of rivastigmine in patients with dementia with Lewy bodies: An open label trial. Int. Psychogeriatr., 13: 199-205.
24. Hashimoto, Y., Abiru, Y., Nishio, C. and Hatanaka, H. (1999) Synergistic effects of brain-derived neurotrophic factor and ciliary neurotrophic factor on cultured basal forebrain cholinergic neurons from postnatal 2-week old rats. Brain Res. Devel. Brain Res., 115: 25-32.
25. Hoffer, A. and Osmond, H. (1964) The Hallucinogens. Academic Press, New York.
26. Hohmann, C.F., Kwiterovich, C., Oster-Granite, M.L. and Coyle, J.T. (1991a) Newborn basal forebrain lesions disrupt cortical cytodifferentiation as visualized by Rapid Golgi staining. Cerebral Cortex, 1: 143-157.
27. Hohmann, C.F. and Berger-Sweeney, J. (1998) Cholinergic regulation of cortical development and plasticity. New Twists to an old story. Perspect. Dev. Neurobiol., 5: 401-425.
28. Huttenlocher, P.R. (1975) Synaptic and dendritic development and mental defect. In: Brain Mechanism in Mental Retardation (M. Brazier, ed.) 123-139.
29. Lainhart, J.E. and Piven, J. (1995) Diagnosis, treatment and neurobiology of Autism in children. Curr. Opin. Paediatrics, 7: 392-400.
30. Martin-Ruiz, C., Court, J.A., Molnar, E., Lee, M., Gotti, C., Mamalaki, A., Tsouloufis, T., Tzartos, S., Ballard, C., Perry, R.H., Perry, E.K. (1999) Alpha4 but not alpha3 and alpha7 nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer's disease. J. Neurochem., 73: 1635-1640.
31. Marubio, L.M., del Mar Arroyo-Jimenez, M., Cordero-Erausquin, M., Lena, C., Le Novere, N., de Kerchove d'Exaerde, A., Huchet, M., Damaj, M.I. and Changeux, J.P. (1999) Reduced antinociception in mice lacking neuronal nicotinic receptor subunits. Nature, 398(6730): 805-810.
32. McAlonan, K. and Brown, V.J. (2002) The thalamic reticular nucleus: more than a sensory nucleus? Neuroscientist, 8: 302-305.
33. McKeith, I., Fairbairn, A., Perry, R., Thompson, P. and Perry, E. (1992a) Neuroleptic sensitivity in patients with senile dementia of Lewy body type. Brit. Med. J., 305: 673-678.
34. McKeith, I.G., Galasko, D., Kosaka, K. et al. (1996) Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology, 47: 1113-1124.
35. McKeith, I.G., Spano, P.F., Del Ser, T., Emre, M., Wesnes, K., Anand, R., Cicin-Sain, A., Ferrara, R. and Spiegel, R. (2000b) Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet, 356: 2031-2036.
36. Mesulam, M.M. (1995) Cholinergic pathways and the ascending reticular activating system of the human brain. Ann. N.Y. Acad. Sci., 757: 169-179.
37. Minshaw, N.J., Sweeney, J.A. and Bauman, M. (1997) Neurological aspects of Autism. In: H. Cohen and F. Volkmar (Eds.), Handbook of Autism and Developmental Disorders. John Wiley & Sons, pp. 360-360.
38. Mirza, N.R. and Stolerman, I.P. (2000) The role of nicotinic and muscarinic acetylcholine receptors in attention. Psychopharmacology, (Berl), 148: 243-250.
39. Nelson, K.B., Grether, J.K., Croen, L.A., Dam brosia, J.M., Dickens, B.F., Jelliffe, L.L., Hansen, R.L. and Phillips, T.M. (2001) Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation. Ann. Neurol., 49: 597-606.
40. Pennell, P.B., Burdette. D.E., Ross, D.A., Henry, T.R., Albin, R.L., Sackellares, J.C. and Frey, K.A. (1999) Muscarinic receptor loss and perservation of presynaptic cholinergic terminals in hippocampal sclerosis. Epilepsia., 40: 38-46.
41. Perry, E., Ashton, H. and Young, A. (Eds.), (2000) Neurochemistry of Consciousness. John Benjamins Oublishing Company, Amsterdam.
42. Perry, E.K. and Young, A.H. (2002) Neurotransmitter systems. In: E. Perry, H. Ashton and A. Young (Eds.), Neurochemistry of Consciusness. John Benjamins, Amsterdam, pp. 3-24.
43. Perry, E., Walker, M., Grace, J. and Perry, R. (1999) Acetylcholine in mind: a neurotransmitter correlate of consciousness? Trends Neurosci., 22: 273-280.
44. Perry, E.K., Lee, M., Martin-Ruiz, C.M., Court, J., Volsen, S., Iversen, P., Bauman, M., Perry, R. and Wenk, G. (2001) Cholinergic activities in autism: abnormalities in the cerebral cortex and basal forebrain. Am. J. Psychiat., 158: 1058-1066.
45. Perry, E.K., McKeith, I., Thompson, P., Marshall, E., Kerwin, J., Jabeen, S., Edwardson, J.A., Ince, P., Blessed, G. and Irving, D. (1991) Topography, extent, and clinical relevance of neurochemical deficits in dementia of Lewy body type, Parkinson's disease, and Alzheimer's disease. Ann. N.Y. Acad. Sci., 640: 197-202.
46. Perry, E.K., Smith, C.J., Court, J.A. and Perry, R.H. (1990) Cholinergic nicotinic and muscarinic receptors in dementia of Alzheimer, Parkinson and Lewy body types. J. Neural. Transm. Park. Dis. Dement. Sect., 2: 149-158.
47. Perry, E.K. and Piggott, M.A. (2000) Behavioural Brain Sciences.
48. Perry, R.H., Irving, D., Blessed, G., Fairbairn, A.F. and Perry, E.K. (1990) Senile dementia of the Lewy body type: a clinically and neuropathologically distinct form of Lewy body disease. J. Neurol. Sci., 95: 119-139.
49. Picciotto, M.R., Zoli, M. and Changeux, J.P. (1999) Use of knock-out mice to determine the molecular basis for the actions of nicotine. Nicotine Tob. Res., 2: 121-125.
50. Rogers, S.W., Gahring, L.C. and Collins, A.C. (1998) Marks M: Age related changes in neuronal nicotinic acetylcholine receptors subunit α4 expression are modified by long term nicotine administration. J. Neurosci., 18: 4825-4832.
51. Sabbagh, M.N., Reid, R.T., Corey-Bloom, J., Rao, T.S., Hansen, L.A., Alford, M., Masliah, E., Adem, A., Lloyd, G.K. and Thal, L.J. (1998) Correlation of nicotinic binding with neurochemical markers in Alzheimer's disease. J. Neural. Transm., 105: 709-717.
52. Samuel, W., Alford, M., Hofstetter, C.R. and Hansen, L. (1997) Dementia with Lewy bodies versus pure Alzheimer disease: differences in cognition, neuropathology, cholinergic dysfunction, and synapse density. J. Neuropathol. Exp. Neurol., 56: 499-508.
53. Sandberg, P.R., Silver, A.A., Shytle, R.D., Philipp, M.K., Cahill, D.W., Fogelson, H.M. and McConville, B.J. (1997) Nicotine for the treatment of Tourette's syndrome. Pharmacol. Ther., 74: 21-25.
54. Shea, C., MacKnight, C. and Rockwood, K. (1998) Donepezil for treatment of dementia with Lewy bodies: a case series of nine patients. Int. Psychogeriatr., 10: 229-238.
55. Shinotoh, H., Aotsuka, A., Ota, T., Tanaka, N., Fukushi, K., Nagatsuka, S., Tanada, S. and Ivie, T. (2001) Brain cholinergic function in dementia with Lewy bodies and Alzheimer's disease measured by PET. Abstracts, Proc 5th Int Conference on Progress in PD and AD, 74.
56. Solms, M. (2000) Dreaming and REM sleep are controlled by different brain mechanisms. Behav. Brain Sci., 23: 843-850.
57. Steinlein, O.K. (2000) Neuronal nicotinic receptors in human epilepsy. Eur. J. Pharmacol., 30, 393: 243-247.
58. Spillantini, M.G., Crowther, R.A., Jakes, R., Hasegawa, M. and Goedert, M. (1998) alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies. Proc. Nat. Acad. Sci. USA., 95: 6469-6473.
59. Tassonyi, E., Charpantier, E., Muller, D., Dumont, L. and Bertrand, D. (2002) The role of nicotinic acetylcholine receptors in the mechanism of anaesthesia, Brain Res. Bul., 133-150.
60. Toichi, M., Kamio, Y., Okado, T., Sakihama, M., Youngstrom, E.A., Findling, R.L. and Yamamoto, K. (2002) A lack of self-consciousness in autism. Am. J. Psychiatry, 159: 1422-1424.
61. Tordjman, S., Antoine, C., Cohen, D.J., Gauvain-Piquard, A., Carlier, M., Roubertoux, P. and Ferrari, P. (1999) Study of the relationships between self-injurious behavior and pain reactivity in infantile Autism. Encephale., 25: 122-134.
62. Trauth, J.A., Seidler, F.J., McCook, E.C. and Slotkin, T.A. (1999) Adolescent nicotine exposure causes persistent upregulation of nicotinic cholinergic receptors in rat brain regions. Brain Res., 851: 9-19.
63. Trevarthen, C. 'Children with Autism', 1996.
64. Wenk, G.L., Naidu, S., Casanova, M.F., Kitt, C.A. and Moser, H. (1991) Altered neurochemical markers in Rett's syndrome. Neurology, 41: 1753-1756.
65. Wesnes, K.A., McKeith, I.G., Ferrara, R., Emre, M., Del Ser, T., Spano, P.F., Cicin-Sain, A., Anand, R. and Spiegel, R. (2002) Effects of rivastigmine on cognitive function in dementia with lewy bodies: a randomised placebo-controlled international study using the cognitive drug research computerised assessment system. Dement. Geriatr. Cogn. Disord., 13: 183-192.
66. Woolf, N.J. (1997) A possible role for cholinergic neurons of the basal forebrain and pontomesencephalon in consciousness. Conscious Cogn., 6: 574-596. Review.
67. Xiang, Z., Huguenard, J.R. and Prince, D.A. (1998) Cholinergic switching within neocortical inhibitory networks. Science, 281: 985-988.
68. Zoli, M., Picciotto, M.R., Ferrari, R., Cocchi, D. and Changeux, J.P. (1999) Increased neurodegeneration during ageing in mice lacking high-affinity nicotine receptors. EMBO J., 18: 1235-1244 D1b.